Company Filing History:
Years Active: 2009-2015
Title: The Innovations of Hong Wang
Introduction
Hong Wang is a notable inventor based in Hamilton, Canada. He has made significant contributions to the field of biomedical research, particularly in the area of gastrointestinal health. With a total of 5 patents to his name, Wang's work focuses on innovative methods for assessing the functionality of GLP-2 receptor modulators.
Latest Patents
One of his latest patents is an ex vivo method for determining potential GLP-2 receptor modulators. This patent discloses a method for measuring the contractility of intestinal tissue upon treatment with GLP-2 or a GLP-2 ligand. Additionally, it introduces an assay that directly measures the activity of GLP-2 or GLP-2 ligands ex vivo, allowing for the screening of putative GLP-2 ligands in native tissue.
Career Highlights
Hong Wang is currently employed at NPS Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the understanding of GLP-2 and its potential therapeutic applications.
Collaborations
Wang collaborates with various professionals in his field, including his coworker Lidia L Demchyshyn, to further his research initiatives and explore new avenues for innovation.
Conclusion
Hong Wang's contributions to the field of biomedical research, particularly through his patents and work at NPS Pharmaceuticals, Inc., highlight his commitment to advancing healthcare solutions. His innovative methods for assessing GLP-2 receptor modulators are paving the way for future developments in gastrointestinal health.